Nortrel Tablet
Product Images NDC 0555-9009

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Nortrel (NDC 0555-9009). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Teva Pharmaceuticals Usa, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Image 1

Chemical structure of Ethinyl Estradiol, one of the active ingredients in Nortrel 21 Day oral tablets containing Norethindrone and Ethinyl Estradiol.*

FDA Label Image

Nortrel® 0.5/35 (norethindrone And Ethinyl Estradiol Tablets Usp) 28 Day Regimen, 3 Blister Cards, 28 Tablets Each Carton, Part 1 Of 2 (Image 10)

The packaging label for Nortrel 21 Day tablets, containing norethindrone and ethinyl estradiol USP in a 1/35 mg strength combination. The label shows a pack with 6 blister cards, each containing 28 tablets, marked for a 28-day regimen. The labeler is Teva Pharmaceuticals USA, Inc. Instructions include storage at 20° to 25°C and a reminder to keep medications out of children's reach. The design features the Teva logo and a QR code for more information.*

FDA Label Image

Nortrel® 0.5/35 (norethindrone And Ethinyl Estradiol Tablets Usp) 28 Day Regimen, 3 Blister Cards, 28 Tablets Each Carton, Part 2 Of 2 (Image 11)

Nortrel 0.5 mg/35 mcg (norethindrone and ethinyl estradiol) oral tablet packaging label by Teva Pharmaceuticals USA, Inc. The label states it contains 3 blister cards with 28 tablets total and is a 28-day regimen. The label includes a warning that the product does not protect against HIV or other sexually transmitted diseases.*

FDA Label Image

Image 12

Nortrel 21 Day (norethindrone and ethinyl estradiol tablets USP) 0.5/35 mg oral tablets in a carton label from Teva Pharmaceuticals USA, Inc. The packaging indicates a 28-day regimen with 3 blister cards containing 28 tablets each. Storage instructions specify controlled room temperature (20° to 25°C). The label includes a QR code for more product information.*

FDA Label Image

Image 2

Chemical structure of the active ingredient, Ethinyl Estradiol, illustrating its molecular framework including hydroxyl groups and an alkyne functional group.*

FDA Label Image

Image 3

Bar chart depicting mortality rates (number of deaths per 100,000 woman-years) across different age groups (15-24, 25-34, 35-44, 45+) segmented by group: Ever Users (Non-Smokers and Smokers) and Controls (Non-Smokers and Smokers). Mortality increases with age, notably higher in Ever Users (Smokers) especially in the oldest age group.*

FDA Label Image

Image 4

A forest plot chart showing effect estimates (odds ratios or relative risks) with confidence intervals from eight different studies examining women's contraceptive use. Studies are labeled by name and year with subdivisions for 'Ever use' and 'Current use'. Horizontal lines and points represent effect estimates and confidence intervals plotted against an axis from -1.5 to 2.0 on the effect estimate scale.*

FDA Label Image

Image 5

Blister pack label for Nortrel 1/35, containing norethindrone and ethinyl estradiol tablets USP. The label shows a 21-day oral dose calendar with three rows of seven circular tablets aligned by days of the week. Storage instructions specify 20° to 25°C (68° to 77°F). The labeler is Teva Pharmaceuticals USA, Inc., with the NDC number 0555-9009-80.*

FDA Label Image

Image 6

Nortrel 21 Day oral tablet blister card for norethindrone and ethinyl estradiol tablets USP, 1/35 strength, by Teva Pharmaceuticals USA, Inc. The card has a 28-day tablet layout with four rows labeled Week 1 to Week 4 and columns labeled Sunday through Saturday. It instructs to store at 20° to 25°C and to take all colored pills before any white pills.*

FDA Label Image

Image 7

Nortrel 21 Day (norethindrone and ethinyl estradiol tablets USP) 1 mg/0.035 mg oral tablets packaging label. The label indicates a 21-day regimen with 3 blister cards, each containing 21 yellow tablets. Manufactured by Teva Pharmaceuticals USA, Inc. The packaging includes warnings about contraception and HIV protection.*

FDA Label Image

Image 8

Packaging label for Nortrel 21 Day tablets USP containing norethindrone and ethinyl estradiol 1/35 mg strength. The box states it contains 3 blister cards with 21 tablets each, for a 21-day regimen, labeled by Teva Pharmaceuticals USA, Inc. Storage instructions specify 20° to 25°C (68° to 77°F).*

FDA Label Image

Image 9

Nortrel 21 Day tablet packaging label for oral contraceptive tablets containing norethindrone and ethinyl estradiol USP, 1 mg/0.035 mg strength. The label describes a 28-day regimen with 6 blister cards each containing 28 tablets. The labeler is Teva Pharmaceuticals USA, Inc. Packaging includes regulatory notices, NDC 0555-9010-58, and branding related to shaping women's health.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.